Justin McCue
Chief Tech/Sci/R&D Officer at TSCAN THERAPEUTICS, INC.
Profile
Justin McCue is currently the Chief Technology Officer at TScan Therapeutics, Inc. He previously held the position of Chief Technology Officer at Avectas Ltd.
and Vice President-Technical Operations at Repertoire Immune Medicines, Inc. Dr. McCue completed his undergraduate degree at the University of California, Berkeley.
Justin McCue active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-12-03 |
Former positions of Justin McCue
| Companies | Position | End |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Avectas Ltd.
 Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Avectas Ltd. provides cellular biotechnology solutions. It develops cell engineering technology called Solupore which permeabilizes the target cell membrane and allows transfer of cargo into cells. The company was founded by Shirley O? Dea and Michael Maguire in 2012 and is headquartered in Kildare, Ireland. | Chief Tech/Sci/R&D Officer | - |
Training of Justin McCue
| University of California, Berkeley | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Avectas Ltd.
Avectas Ltd. Miscellaneous Commercial ServicesCommercial Services Avectas Ltd. provides cellular biotechnology solutions. It develops cell engineering technology called Solupore which permeabilizes the target cell membrane and allows transfer of cargo into cells. The company was founded by Shirley O? Dea and Michael Maguire in 2012 and is headquartered in Kildare, Ireland. | Commercial Services |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Justin McCue
